This conversation starts with Roger Green using an old marketing research question. He asks each panelist to divide 100 points of potential to change between Stephen’s multi-slide concept, drug development as exemplified by the EFX trial and advances in NITs as exemplified by MRE. The group each comes to different answers and uses different logic to get there. Listen to their thinking to decide what you can learn from each of them and where you disagree.